ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 39 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $93,000 | -44.3% | 842,203 | +20.3% | 0.00% | – |
Q2 2020 | $167,000 | +122.7% | 700,163 | +114.4% | 0.00% | – |
Q2 2019 | $75,000 | -39.0% | 326,583 | -6.8% | 0.00% | – |
Q1 2019 | $123,000 | -71.6% | 350,568 | -0.4% | 0.00% | – |
Q4 2018 | $433,000 | -34.4% | 351,842 | -0.4% | 0.00% | – |
Q3 2018 | $660,000 | +358.3% | 353,334 | +450.2% | 0.00% | – |
Q2 2018 | $144,000 | – | 64,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cambridge Investment Research Advisors, Inc. | 12,079,080 | $22,588,000 | 0.22% |
jvl associates llc | 58,500 | $109,000 | 0.10% |
Sigma Planning Corp | 26,642 | $50,000 | 0.00% |
TCI Wealth Advisors, Inc. | 180 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,142 | $4,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 11,295 | $21,000 | 0.00% |
NORTHERN TRUST CORP | 353,334 | $660,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 13,172 | $25,000 | 0.00% |
Legal & General Group Plc | 5,852 | $11,000 | 0.00% |